Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

Tuekprakhon, Aekkachai; Nutalai, Rungtiwa; Dijokaite-Guraliuc, Aiste; Zhou, Daming; M. Ginn, Helen; Selvaraj, Muneeswaran; Liu, Chang; J. Mentzer, Alexander; Supasa, Piyada; M. E. Duyvesteyn, Helen; Das, Raksha; Skelly, Donal; Ritter, Thomas; Amini, Ali; Bibi, Sagida; Adele, Sandra; A. Johnson, Síle; Constantinides, Bede; J. Webster, Hermione; Temperton, Nigel; Klenerman, Paul; Barnes, Eleanor; Dunachie, Susanna; W. Crook, Derrick; J. Pollard, Andrew; Lambe, Teresa; Goulder, Philip; G. Paterson, Neil; A. Williams, Mark; R. Hall, David; P. Conlon, Christopher; Deeks, Alexandra; Frater, John; Frending, Lisa; Gardiner, Siobhan; Jämsén, Anni; Jeffery, Katie; Malone, Tom; Phillips, Eloise; Rothwell, Lucy; Stafford, Lizzie; E. Fry, Elizabeth; Huo, Jiandong; Mongkolsapaya, Juthathip; Ren, Jingshan; I. Stuart, David; Screaton, Gavin

doi:10.1016/j.cell.2022.06.005

Public

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

Published in Cell • Jun 9, 2022

Authors:

Aekkachai Tuekprakhon

Rungtiwa Nutalai

Aiste Dijokaite-Guraliuc

Abstract

The Omicron lineage of SARS-CoV-2, which was first described in November 2021, spread rapidly to become globally dominant and has split into a number of sublineages. BA.1 dominated the initial wave but has been replaced by BA.2 in many countries. Recent sequencing from South Africa's Gauteng region ...

Subject

Biology

Virology

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!